Special: One Stock… 357% gains… Same Date Every Year.



SBBP: Strongbridge Biopharma is a Buy

The current rating for SBBP is 100, which is 100% above its historic median rating of 50. This indicates lower risk than normal.

The rating is currently showing a higher than normal reading, suggesting risk levels could be lower than normal.